[1]
Asma Luqman and Qurat ul Ain Ghouri 2025. Comparison of the Effectiveness and Safety of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients with Overweight or Obesity. Journal of Health, Wellness and Community Research. 3, 7 (Jul. 2025), 1–11. DOI:https://doi.org/10.61919/q7nc4n17.